STAT+: Congressional advisers call to rein in Medicare Ad...

What’s Happening

Okay so Lobbying groups backed by insurance companies have called out the research and promoted their own.

The Readout The Readout STAT Plus: FDA launches unified system for adverse event reports By Meghana Keshavan The Readout The Readout STAT Plus: FDA approves leucovorin for rare disorder without trial data By Elaine Chen Health Care Inc. STAT Plus: The ER staffing conflict, and no facility fee for a marmot By Bob Herman The Readout The Readout STAT Plus: A setback for Roches breast cancer drug By Meghana Keshavan A STAT Examination A STAT Examination STAT Plus: After UnitedHealth moved in, Oregon sought to rein in corporate health care. (shocking, we know)

Now, it’s facing an early test By Tara Bannow STAT Plus: A top biotech VC quietly helped Epstein’s ‘solid friend’ make a comeback By Damian Garde STAT Plus: 5 lessons from Vinay Prasads turbulent tenure at the FDA By Matthew Herper STAT Plus: The FDA is targeting telehealth marketing of GLP-1 drugs.

Why This Matters

By Katie Palmer STAT Plus: After UnitedHealth moved in, Oregon sought to rein in corporate health care.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Are you here for this or nah?